Filing Details

Accession Number:
0000950103-20-015544
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-10 17:29:07
Reporting Period:
2020-08-06
Accepted Time:
2020-08-10 17:29:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642545 Shockwave Medical Inc. SWAV () I0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1616320 Fcpr Vii Capital Sofinnova C/O Shockwave Medical, Inc.
5403 Betsy Ross Drive
Santa Clara CA 95054
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-06 46,427 $50.77 2,559,391 No 4 S Direct
Common Stock Disposition 2020-08-06 25,295 $51.22 2,534,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares held by the reporting person are also reported on Form 4 by Antoine Papiernik, one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of the reporting person. Mr. Papiernik disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
  2. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $50.08 to $51.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  3. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $51.08 to $51.58. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.